Clinical heterogeneity ofde novo11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic clone
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical heterogeneity ofde novo11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic clone
Authors
Keywords
-
Journal
HEMATOLOGICAL ONCOLOGY
Volume 31, Issue 2, Pages 88-95
Publisher
Wiley
Online
2012-10-02
DOI
10.1002/hon.2028
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Importance of genetics in chronic lymphocytic leukemia
- (2011) Thorsten Zenz et al. BLOOD REVIEWS
- A Pathobiological Role of the Insulin Receptor in Chronic Lymphocytic Leukemia
- (2011) K. Saiya-Cork et al. CLINICAL CANCER RESEARCH
- Insulin Receptor Activation in Deletion 11q Chronic Lymphocytic Leukemia
- (2011) J. R. Brown CLINICAL CANCER RESEARCH
- 13q14 Deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia
- (2011) Michele Dal Bo et al. GENES CHROMOSOMES & CANCER
- Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia
- (2011) R. Gunnarsson et al. HAEMATOLOGICA
- Multivariable Model for Time to First Treatment in Patients With Chronic Lymphocytic Leukemia
- (2011) William G. Wierda et al. JOURNAL OF CLINICAL ONCOLOGY
- SF3B1and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia
- (2011) Lili Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Moving from prognostic to predictive factors in chronic lymphocytic leukaemia (CLL)
- (2010) Thorsten Zenz et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
- (2010) M Hallek et al. LANCET
- Karyotype-specific microRNA signature in chronic lymphocytic leukemia
- (2009) R. Visone et al. BLOOD
- De novo deletion 17p13.1 chronic lymphocytic leukemia shows significant clinical heterogeneity: the M. D. Anderson and Mayo Clinic experience
- (2009) C. S. Tam et al. BLOOD
- A comprehensive evaluation of the prognostic significance of 13q deletions in patients with B-chronic lymphocytic leukaemia
- (2009) Daniel L. Van Dyke et al. BRITISH JOURNAL OF HAEMATOLOGY
- Chemoimmunotherapy may overcome the adverse prognostic significance of 11q deletion in previously untreated patients with chronic lymphocytic leukemia
- (2009) Apostolia-Maria Tsimberidou et al. CANCER
- A high number of losses in 13q14 chromosome band is associated with a worse outcome and biological differences in patients with B-cell chronic lymphoid leukemia
- (2009) J. A. Hernandez et al. HAEMATOLOGICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started